BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 11972032)

  • 1. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a.
    Papadatos GA; Wallerstein PM; Head CE; Ratcliff R; Brady PA; Benndorf K; Saumarez RC; Trezise AE; Huang CL; Vandenberg JI; Colledge WH; Grace AA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6210-5. PubMed ID: 11972032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia.
    Tan BH; Iturralde-Torres P; Medeiros-Domingo A; Nava S; Tester DJ; Valdivia CR; Tusié-Luna T; Ackerman MJ; Makielski JC
    Cardiovasc Res; 2007 Dec; 76(3):409-17. PubMed ID: 17897635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.
    Leoni AL; Gavillet B; Rougier JS; Marionneau C; Probst V; Le Scouarnec S; Schott JJ; Demolombe S; Bruneval P; Huang CL; Colledge WH; Grace AA; Le Marec H; Wilde AA; Mohler PJ; Escande D; Abriel H; Charpentier F
    PLoS One; 2010 Feb; 5(2):e9298. PubMed ID: 20174578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization.
    Watanabe H; Nogami A; Ohkubo K; Kawata H; Hayashi Y; Ishikawa T; Makiyama T; Nagao S; Yagihara N; Takehara N; Kawamura Y; Sato A; Okamura K; Hosaka Y; Sato M; Fukae S; Chinushi M; Oda H; Okabe M; Kimura A; Maemura K; Watanabe I; Kamakura S; Horie M; Aizawa Y; Shimizu W; Makita N
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):874-81. PubMed ID: 22028457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sick sinus syndrome, progressive cardiac conduction disease, atrial flutter and ventricular tachycardia caused by a novel SCN5A mutation.
    Holst AG; Liang B; Jespersen T; Bundgaard H; Haunso S; Svendsen JH; Tfelt-Hansen J
    Cardiology; 2010; 115(4):311-6. PubMed ID: 20395683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of reentrant spontaneous polymorphic ventricular tachycardia in a Scn5a+/- mouse model.
    Martin CA; Guzadhur L; Grace AA; Lei M; Huang CL
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1853-62. PubMed ID: 21378142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.
    Neu A; Eiselt M; Paul M; Sauter K; Stallmeyer B; Isbrandt D; Schulze-Bahr E
    Hum Mutat; 2010 Aug; 31(8):E1609-21. PubMed ID: 20564468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p.N1380del mutation in the pore-forming region of SCN5A gene is associated with cardiac conduction disturbance and ventricular tachycardia.
    Yang Z; Lu D; Zhang L; Hu J; Nie Z; Xie C; Qiu F; Cheng H; Yan Y
    Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):270-276. PubMed ID: 28159958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a.
    Lei M; Goddard C; Liu J; Léoni AL; Royer A; Fung SS; Xiao G; Ma A; Zhang H; Charpentier F; Vandenberg JI; Colledge WH; Grace AA; Huang CL
    J Physiol; 2005 Sep; 567(Pt 2):387-400. PubMed ID: 15932895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium channel (dys)function and cardiac arrhythmias.
    Remme CA; Bezzina CR
    Cardiovasc Ther; 2010 Oct; 28(5):287-94. PubMed ID: 20645984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy.
    Remme CA; Scicluna BP; Verkerk AO; Amin AS; van Brunschot S; Beekman L; Deneer VH; Chevalier C; Oyama F; Miyazaki H; Nukina N; Wilders R; Escande D; Houlgatte R; Wilde AA; Tan HL; Veldkamp MW; de Bakker JM; Bezzina CR
    Circ Res; 2009 Jun; 104(11):1283-92. PubMed ID: 19407241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system.
    Bezzina CR; Rook MB; Groenewegen WA; Herfst LJ; van der Wal AC; Lam J; Jongsma HJ; Wilde AA; Mannens MM
    Circ Res; 2003 Feb; 92(2):159-68. PubMed ID: 12574143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sodium-channel mutation causes isolated cardiac conduction disease.
    Tan HL; Bink-Boelkens MT; Bezzina CR; Viswanathan PC; Beaufort-Krol GC; van Tintelen PJ; van den Berg MP; Wilde AA; Balser JR
    Nature; 2001 Feb; 409(6823):1043-7. PubMed ID: 11234013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD.
    Remme CA; Verkerk AO; Nuyens D; van Ginneken AC; van Brunschot S; Belterman CN; Wilders R; van Roon MA; Tan HL; Wilde AA; Carmeliet P; de Bakker JM; Veldkamp MW; Bezzina CR
    Circulation; 2006 Dec; 114(24):2584-94. PubMed ID: 17145985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction.
    Hu D; Viskin S; Oliva A; Carrier T; Cordeiro JM; Barajas-Martinez H; Wu Y; Burashnikov E; Sicouri S; Brugada R; Rosso R; Guerchicoff A; Pollevick GD; Antzelevitch C
    Heart Rhythm; 2007 Aug; 4(8):1072-80. PubMed ID: 17675083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.
    Smits JP; Koopmann TT; Wilders R; Veldkamp MW; Opthof T; Bhuiyan ZA; Mannens MM; Balser JR; Tan HL; Bezzina CR; Wilde AA
    J Mol Cell Cardiol; 2005 Jun; 38(6):969-81. PubMed ID: 15910881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannitol and hyponatremia regulate cardiac ventricular conduction in the context of sodium channel loss of function.
    Blair GA; Wu X; Bain C; Warren M; Hoeker GS; Poelzing S
    Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H724-H734. PubMed ID: 38214908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy.
    Laurent G; Saal S; Amarouch MY; Béziau DM; Marsman RF; Faivre L; Barc J; Dina C; Bertaux G; Barthez O; Thauvin-Robinet C; Charron P; Fressart V; Maltret A; Villain E; Baron E; Mérot J; Turpault R; Coudière Y; Charpentier F; Schott JJ; Loussouarn G; Wilde AA; Wolf JE; Baró I; Kyndt F; Probst V
    J Am Coll Cardiol; 2012 Jul; 60(2):144-56. PubMed ID: 22766342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.